This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter: revenue up 15.2%, profit after tax down 58.4% to Rs 17.58 crore
JUBLCPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 Sep 2026: revenue from operations rose 15.2% to Rs 589.82 crore from Rs 511.82 crore in Sep 2025; profit after tax fell 58.4% to Rs 17.58 crore from Rs 42.28 crore. Standalone revenue from operations was Rs 587.69 crore and profit after tax Rs 17.12 crore. Consolidated half-year profit after tax: Rs 63.69 crore versus Rs 86.41 crore; operating cash flow: negative Rs 94.87 crore. Prior figures were reclassified.
Revenue growth helps, but the profit fall and negative operating cash flow may pressure the stock; reclassified comparatives also limit trend clarity.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹589.8 Cr | ₹513.0 Cr | +15.0% |
| Operating profit | ₹17.63 Cr | ₹58.31 Cr | −69.8% |
| Profit after tax | ₹17.58 Cr | ₹42.28 Cr | −58.4% |
| EBITDA margin | 4.4% | 12.5% | −8.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.